New Genentech Medicine for Previously Untreated Chronic Lymphocytic Leukemia
We’re working together to shape the future of biotech. Take a look inside Genentech.
Genentech is committed to ensuring price is not a barrier to access for patients. Learn about our programs.
Announcing Sunshine Track
Physicians can now use our secure online portal to review Sunshine-reportable payments before they are reported to the government.
Search for jobs. Learn more about what is currently available. And then apply for the position at Genentech that’s right for you.
Genentech Disappointed with CA Governor's Veto of Patient Access to Biosimilars Bill
Collaborating With Managed Care
Insights on trends, events, and therapeutic advances. Learn more at Genentech-Forum.com.
Our pipeline includes over 30 new molecular entities that address serious unmet medical needs.
From Molecules to Medicines
Ann Lee-Karlon, Ph.D., SVP of Portfolio Management and operations on how teams and decision making influence drug discovery and development.
At Genentech, our t-shirts represent our stories - about our people, our community, and ultimately about the impact of biotechnology on medicine.
Partnering is a relatively new phenomenon for biopharmaceutical companies, but collaboration has been part of Genentech’s DNA from the beginning.
We partnered on a survey that identified a significant gap in the understanding of diabetes and vision loss. Learn more.
Find links to info and resources on each of our medicines, including prescribing information, material data safety sheets, medication guides, and healthcare provider letters.
From Compassion to Action
This year, honor Mental Illness Awareness Week by learning about schizophrenia and going beyond the stereotypes.
Genentech EVP Wins Lasker Award
Congratulations Richard Scheller, Ph.D., EVP - Research and Early Development on his receipt of the Lasker Award for advances in Neuroscience.